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Pure a-latrotoxin is very inefficient at forming chan-
nels/pores in artificial lipid bilayers or in the plasma
membrane of non-secretory cells. However, the toxin
induces pores efficiently in COS-7 cells transfected with
the heptahelical receptor latrophilin or the monotopic
receptor neurexin. Signaling-deficient (truncated) mu-
tants of latrophilin and latrophilin-neurexin hybrids
also facilitate pore induction, which correlates with
toxin binding irrespective of receptor structure. This
rules out the involvement of signaling in pore formation.
With any receptor, the a-latrotoxin pores are permeable
to Ca21 and small molecules including fluorescein iso-
thiocyanate and norepinephrine. Bound a-latrotoxin re-
mains on the cell surface without penetrating com-
pletely into the cytosol. Higher temperatures facilitate
insertion of the toxin into the plasma membrane, where
it co-localizes with latrophilin (under all conditions)
and with neurexin (in the presence of Ca21). Interest-
ingly, on subsequent removal of Ca21, a-latrotoxin dis-
sociates from neurexin but remains in the membrane
and continues to form pores. These receptor-indepen-
dent pores are inhibited by anti-a-latrotoxin antibodies.
Our results indicate that (i) a-latrotoxin is a pore-form-
ing toxin, (ii) receptors that bind a-latrotoxin facilitate
its insertion into the membrane, (iii) the receptors are
not physically involved in the pore structure, (iv) a-lat-
rotoxin pores may be independent of the receptors, and
(v) pore formation does not require a-latrotoxin inter-
action with other neuronal proteins.
a-Latrotoxin (LTX)1 stimulates sustained release of various
neurotransmitters and some peptides from nerve terminals
and endocrine cells but has a complex mechanism of action
(1–6). Importantly, before exerting any of its effects, the toxin
binds to presynaptic receptors (7): neurexin Ia (NRX) (8) and
latrophilin (LPH), also called CIRL (9, 10). NRX, a single-pass
transmembrane neuronal protein, resembles cell-contact mol-
ecules and interacts with LTX only in the presence of Ca21 (8,
11, 12). LPH binds LTX strongly under all conditions tested
and, as a neuron-specific G protein-coupled receptor, is likely to
mediate intracellular signaling (13, 14).
One of the major effects of LTX binding to its receptors is the
induction of cation-permeable channels, or pores, in the cell
membrane (2, 6, 15). The pores play a profound role in the
action of the toxin; (i) influx of Ca21 or other cations through
such pores can cause neurotransmitter release (12, 16–18), and
(ii) cytoplasmic neurotransmitters, including ATP, can leak out
directly through these pores (1, 12, 19, 20). However, the mech-
anism by which LTX induces the pores and the role of the
receptors in this action remain largely unknown. The receptors
could (i) mediate intracellular signaling leading to the opening
of endogenous channels, (ii) participate in the pore structure or
(iii) simply tether LTX to the cell surface, thus allowing its
insertion into the membrane to form pores. In addition, other
(non-receptor) proteins of the exocytotic apparatus could par-
ticipate in pore induction upon direct stimulation by the toxin.
On the other hand, LTX preparations can permeabilize artifi-
cial lipid bilayers (21–23) and form pore-like tetrameric struc-
tures in liposomes (24), suggesting that, under some conditions,
the toxin is able to make pores even in the absence of any
receptors. It is unclear, however, whether LTX acts in the same
way upon binding to LPH or NRX and whether these receptors
are physically involved in the structure of the LTX pore.
The objective of this work was to analyze the roles that LPH
and NRX play in pore formation by LTX. We found that, in
contrast to the crude venom, highly purified LTX in physiolog-
ical concentrations is very inefficient in forming pores in lipid
bilayers or receptor-less cells. When expressed in non-secretory
cells, the receptors, including signaling-deficient mutants,
tether LTX to the plasma membrane with subsequent forma-
tion of large pores permeable to ions and small molecules.
These pores remain open in the membrane even after LTX
dissociation from the receptor(s) and can be blocked by anti-
LTX antibody (Ab). Our findings suggest that LTX is the sole
component of the pores but only inserts efficiently into the
plasma membrane if recruited by any of its receptors.
EXPERIMENTAL PROCEDURES
Materials—Bilayer lipids were purchased from Avanti; other re-
agents were from Sigma. LTX was purified from the venom of Latro-
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dectus lugubris as described (25). Briefly, lyophilized venom was dis-
solved in buffer B (50 mM Tris-HCl, pH 8.3, 0.15 M NaCl) containing 20
mM EDTA, applied on to a high performance gel filtration column
KW-803 (Waters) and eluted with buffer A. Fractions containing LTX
were subjected to ion exchange chromatography on a Protein-Pak Q
AP-1 column (Waters) eluted with a gradient of NaCl. The LTX fraction
(corresponding to conventional toxin preparations (34)) was further
purified by preparative native electrophoresis using a 3.5-cm-long 6%
polyacrylamide gel cast in a model 491 Prep Cell (Bio-Rad). The elec-
trophoresis buffer contained 25 mM Tris-HCl, 192 mM glycine, pH 8.3.
Electrophoresis was carried out overnight at 200 V, with continuous
elution of proteins (monitored at 280 nm). LTX was pooled and concen-
trated to 2–7 mM using a Centriprep 30 unit (Amicon). Proteins obtained
after each stage of purification were carefully tested by SDS-polyacryl-
amide gel electrophoresis and immunoblotting and assayed for toxicity,
receptor binding, and transmitter release (25).
Channel Formation in Lipid Bilayers—Planar bilayers were formed
from pure lipids suspended at a total concentration of 30 mg/ml in
n-decane (Aldrich). Membranes containing POPE, equimolar POPE/
POPS, or an equimolar mixture of POPE, POPS, POPC, and cholesterol
were cast across a 0.3-mm-diameter hole in a polystyrene partition
separating two solution-filled chambers as described elsewhere (48, 49).
Unless otherwise stated, the bilayers were exposed to symmetric 100
mM KCl buffered with 10 mM Tris-HCl, pH 7.4. The membranes were
voltage-clamped using a Biologic RK-300 patch clamp amplifier (Intra-
cel, UK), and transmembrane currents were low pass-filtered at 1–10
kHz (23-db point, 8-pole Bessel-type response) and recorded.
Experiments were only carried out with membranes that thinned
spontaneously to give a capacitance of at least 250 picofarads and a
conductance of ,10 picosiemens; junction potentials were routinely
nulled to within 6 1 mV. The cis side of the bilayer (the side to which
LTX was added) was voltage-clamped relative to the trans side, which
was grounded, and we followed the standard electrophysiological cur-
rent convention (i.e. positive currents flowing cis to trans are shown as
positive, up-going currents). The contents of the chambers were
changed by perfusion ($10 volumes) as required. Data were post-fil-
tered and digitally sampled at 5 times the filter corner frequency for
analysis using pClamp 6 (Axon) and other programs. Relative ion per-
meabilities were calculated from reversal potentials measured under
bi-ionic conditions using appropriate forms of the Goldman-Hodgkin-
Katz and Fatt-Ginsborg equations.
Recombinant Receptors—Rat latrophilin cDNA in pBlueScript (13)
was cleaved with HindIII and EcoRI restrictases and subcloned into the
same sites of the pcDNA3.1 vector (Invitrogen). To produce LPH-FS
lacking the 59-untranslated region, the fragment between the HindIII
and BamHI sites of the initial construct was replaced with a shorter
fragment, which was polymerase chain reaction (PCR)-amplified be-
tween primers CGTGCCCGCCCCAAGCTTTCGCCA (N77) and
GGGTCCGCAGGTCATATTTG. Latrophilin deletion mutants LPH-
7TM and LPH-5TM were prepared by PCR between N77 and oligonu-
cleotides GCACTTGCTGTACTTCTAGAGCACCTTTTT or ATGAGCT-
TCGGATCATCTAGAGCAGGGTC, respectively, using latrophilin
cDNA as a template. These fragments were then digested with HindIII
and XbaI and ligated into the respective sites of pcDNA3.1. For LPH-
1TM, LPH-FS was cleaved with HpaI and NotI, and the deleted piece
was replaced with a fragment obtained by PCR between primers
GGAGAATGCCACAGTGAAGCTGGCAGGTGAG and AGGAAGCG-
GCCGCTGCACAGTTACTTGTGGATG (cut with the same enzymes).
To make the LPH-NRX hybrid, an intermediate construct was prepared
by replacing the XhoI/XbaI segment of the LPH-FS with a PCR-ampli-
fied fragment between primers AAGGGAACTCGAGGAATTGCCTCG
and GGCCTCTAGAGAAGCAGAAGGTGG. Another fragment, ob-
tained by PCR (between CTTCTCTATGCTAGCTACAAGTACAG and
TAAAAACAGTCTAGACTTCCTGATTGCA) on the NRX template and
cut with NheI and XbaI, was then introduced into the XbaI site of the
intermediate construct. The full-size neurexin construct was prepared
by directly subcloning a KpnI-BglII fragment of the bovine cDNA for
neurexin Ia into pcDNA3.1. All mutations introduced were verified by
sequencing. DNA for transfection of mammalian cells was prepared
using Qiagen kits. Transfection of COS-7 cells maintained in Dulbecco’s
modified Eagle’s medium (Life Technologies, Inc.) was carried out using
the SuperFect transfection reagent (Qiagen) according to the manufac-
turer’s protocol.
Antibody Preparation—Rabbit polyclonal Ab recognizing the N-ter-
minal domain of LPH was obtained by injecting rabbits with bovine
brain LPH purified by LTX affinity chromatography and SDS-electro-
phoresis (9). The C terminus-specific Ab was obtained by immunizing
rabbits with a fusion protein consisting of glutathione S-transferase
and the LPH C terminus (cDNA fragment 3976–4856). LPH fusion
proteins were constructed to affinity purify these Abs; the N-terminal
domain (nucleotides 630–2957) was subcloned into the pGEX-4X vector
in-frame with glutathione S-transferase, whereas the C-terminal do-
main (nucleotides 3976–4856) was cloned into the pQE40 vector (Qia-
gen) in-frame with dihidrofolate reductase. The fusion proteins were
expressed in Escherichia coli, purified by glutathione or Ni21 affinity
chromatography, and spot-blotted onto pieces of Immobilon membrane
(Millipore). These were used to purify the LPH-specific Ab from respec-
tive sera as described (50). Anti-NRX Ab was elicited in rabbits injected
with keyhole limpet hemocyanin conjugated with the NRX C-terminal
peptide (CSANKNKKNKDKEYYV) and affinity-purified using this
peptide immobilized on thiol-Sepharose (Amersham Pharmacia
Biotech).
Immunostaining Procedures—COS-7 cells were grown on multi-well
chamber slides (Nunc) and transfected as described above. One day
after transfection, the cells were washed with PBS, fixed with 4%
paraformaldehyde in PBS for 30 min at room temperature, and washed
again. Nonspecific binding sites were blocked by a 20-min incubation
with 3% (w/v) goat serum (Life Technologies, Inc.). In some experi-
ments, the cells were permeabilized with 0.05% Triton X-100. The
specimens were then incubated for 1 h with the respective primary Ab,
washed, incubated with a fluorescein-conjugated anti-rabbit IgG (Sig-
ma), washed, mounted using Vectashield mounting medium (Vector
Laboratories), and analyzed by confocal laser-scanning microscopy. In
some experiments, a fluorescent derivative of LTX was used, which was
obtained using the FluoroLink mAb labeling kit (Amersham Pharmacia
Biotech) according to the manufacturer’s protocol. In immunocytochem-
ical experiments, the distribution pattern of the fluorescently labeled
LTX was identical to that of immunostained toxin.
For immunoblotting, COS-7 cells were detached from plates in ice-
cold PBS and pelleted by centrifugation. The pellets were then dissolved
in electrophoresis sample buffer containing 2% SDS, 100 mM dithio-
threitol, and 8 M urea (105 cells/50 ml of buffer) for 30 min at 37 °C and
separated in 6% SDS-polyacrylamide gels not containing urea. After
electrophoresis, the proteins were transferred onto Immobilon mem-
brane (Millipore) and visualized using primary Ab, goat anti-rabbit
peroxidase-conjugated IgG, and chemiluminescent substrate (Pierce)
followed by exposure onto x-ray film.
Confocal Microscopy—Specimens were imaged with a LSM 510 sys-
tem (Zeiss) mounted on an upright microscope (Axioplan-2, Zeiss) using
dual excitation at 488 and 633 nm. Light emitted by doubly stained
preparations was analyzed using a combination of an FITC-type narrow
band-pass filter block (505–530 nm) and a long-pass filter block ($650
nm). Images were collected using oil immersion objective (Plan-
Neofluar, 403/1.3, Zeiss) for fixed samples or a water immersion objec-
tive (Achroplan, 403 W/0.8, Zeiss) for submerged unfixed samples. To
quantify the degree of co-localization, scatter diagrams for doubly
stained samples were produced using the LSM 510 software (Zeiss). In
such diagrams, the brightness of each pixel in the red channel (Cy5-
LTX) is interpreted as X coordinate, and that in the green channel
(immunostained NRX) is interpreted as Y coordinate; coordinates of
pixels that have similar intensity in both channels (co-localization)
appear near the diagonal running from bottom left to top right of the
graph.
Binding Experiments—LTX was iodinated as described earlier (34).
When binding experiments were performed on culture plates, the cells
were incubated with 1 nM iodinated LTX in buffer A (145 mM NaCl, 5
mM KCl, 1.2 mM NaH2PO4, 2 mM MgCl2, 10 mM glucose, 20 mM HEPES,
pH 7.4) in the presence or absence of 2 mM CaCl2, then washed with this
buffer. Bound toxin was eluted from plates with 1% Triton X-100.
Alternatively, cells were scraped off the plates into PBS, counted, then
incubated with increasing concentrations of [125I]LTX and filtered
through GF/F glass fiber filters (Whatman). Nonspecific binding was
determined in the presence of a 100-fold excess of unlabeled toxin. The
radioactivity of the Triton eluate from plates and of the filters was
measured in a g-spectrometer.
LTX-induced Influx into COS-7 Cells—For influx experiments, cells
were plated at 50% confluence on 6-well tissue culture plates, trans-
fected with control or receptor plasmids, and 24 h later, used in meas-
urements of LTX-stimulated influx of 45Ca21, [3H]NE, or FITC.
For 45Ca21 influx, the cells were washed twice with buffer A and
incubated at room temperature for 5 min in the same buffer supple-
mented with 2 mM CaCl2 and 2–4 mCi/ml
45Ca21. One to five min after
the addition of 1–2 nM LTX, the cells were quickly washed twice with
buffer A. Alternatively, the toxin pores were pre-formed in cells before
the addition of 45Ca21. For this purpose, the cells were incubated with
1 nM LTX, washed with 0.2 mM EGTA, and kept in buffer A without
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Ca21 for a further 10–30 min at room temperature (anti-LTX serum or
purified IgG fraction was included in some experiments at this stage);
influx was initiated by the addition of Ca21/45Ca21. In all cases, after
the final wash, the cells were lysed in 0.5 ml of 10 mM EDTA and 1%
Triton X-100. The lysate was mixed with 10 ml of UltimaGold scintil-
lation mixture (Packard), and its radioactivity was determined in a
b-spectrometer.
[3H]NE influx was measured in receptor- or vector-transfected cells
either by simultaneously adding LTX and 0.5–2.5 mCi of [3H]NE or by
pre-forming LTX pores as above, with subsequent addition of the label.
Influx was determined after 5 min by washing and lysing the cells.
To measure FITC influx, the cells were briefly washed with buffer A
(plus/minus 2 mM Ca21) before the addition of 5 mM FITC with or
without 4 nM LTX. After a 10-min incubation, the cells were extensively
washed with buffer A and immediately examined by confocal micros-
copy using a water immersion objective.
RESULTS
LTX Pores in Lipid Bilayers and Cells—Recently, we intro-
duced a new improved LTX purification procedure (25) that
uses an additional step (preparative native electrophoresis) to
remove several proteins usually contaminating conventional
LTX preparations (26). The resulting highly purified LTX is
fully active in biochemical and physiological tests (25). Here,
we compared the ability of this pure LTX and the crude spider
venom to form channels in artificial planar lipid bilayers (21)
containing different lipids and in the presence or absence of
Ca21. The addition of small amounts of the crude venom (con-
taining as little as 10 pM pure LTX) always gave rise to channel
activity within 2 min (Fig. 1A). Larger doses of the venom
(equivalent to 10 nM LTX) typically gave rise to macroscopic
conductances of .500 nanosiemens. The channels were perme-
able to both Ca21 and K1 and had conductances ranging from
20 to 200 picosiemens, suggesting that the venom contains
several different channel-forming components. Relative
Ca21/K1 selectivities (measured in bi-ionic conditions in palmi-
toyloleoylphosphatidylethanolamine (POPE) bilayers) ranged
from 0.45 6 0.2 (mean 6 S.D., n 5 6) for 60-picosiemens
channels to 1.6 6 0.7 (mean 6 S.D., n 5 6) for 150–200-
picosiemens channels. Partially purified toxin (corresponding
to conventional LTX preparations) was much less active than
the crude venom, typically producing only 1–2 channels despite
prolonged exposure (Fig. 1B).
In contrast, 10 nM pure LTX (i.e. 1000-fold more concentrated
than in the venom) did not give rise to any channel activity
after periods of 20–60 min when added to more than 20 bilay-
ers containing POPE and palmitoyloleoylphosphatidylserine
(POPS), POPE alone, or a POPE/POPS/palmitoyloleoylphos-
phatidylcholine (POPC)/cholesterol mixture, irrespective of the
presence of 2 mM Ca21. The result was the same if membranes
were broken and reformed in the continued presence of LTX. To
illustrate these findings, Fig. 1C shows an experiment using
POPE/POPS/POPC/cholesterol bilayer. 10 nM LTX had no ef-
fect over a prolonged period (note a different time scale), but
there was near-immediate channel activity on stirring in the
venom equivalent to 10 pM LTX (confirming that the bilayer
remained intact and fusion-competent). These findings suggest
that many pore-forming constituents of the venom are gradu-
ally removed from LTX by the purification procedure, resulting
in a pure toxin that is unable to form pores in pure lipid
membranes at physiological concentrations. In one experiment,
we added a bolus of 2 mM LTX to produce a final concentration
of more than 100 nM (Fig. 1D). This did result in immediate
channel activity, suggesting that pure LTX can induce mem-
brane pores provided it is present at extremely high concentra-
tions. Unfortunately, the need for these very large amounts of
pure toxin precluded further, more detailed experiments on
planar bilayers.
On the other hand, nanomolar LTX is known to induce pores
readily in the membranes of neurons and endocrine cells or
even non-secretory cells expressing the toxin receptors (e.g. see
Refs. 17 and 27–29). To investigate this phenomenon, we ap-
plied LTX to COS-7 cells in the presence of extracellular
45Ca21. Consistent with its poor ability to permeabilize pure
lipid bilayers, 2 nM LTX was unable to induce influx of Ca21
into vector-transfected cells (Fig. 1E). Only when the toxin
concentration was elevated to more than 100 nM, did some Ca21
influx occur in control cells (Fig. 1E). However, 2 nM LTX from
the same toxin batch induced a large accumulation of Ca21
(Fig. 1E) by cells that had been transfected with an LPH
expression construct (13); this action required millimolar ex-
tracellular [Mg21] (12, 25). These results indicated that the
receptor was required for the induction of LTX pores by a
mechanism to be determined.
Generation and Features of LTX Receptor Constructs—To
study the possibility that LPH-mediated signal transduction is
involved in the LTX pore formation, we produced a series of
LPH deletion mutants (Fig. 2A). Heptahelical receptors require
their cytoplasmic loops and the cytoplasmic tail in order to
interact functionally with G proteins (30–33), so these domains
were progressively removed in the receptor mutants. As a
result, functional coupling to G proteins was abolished2 in the
mutants LPH-N5TM, LPH-N3TM and LPH-N1TM, which con-
tain five, three, and one transmembrane domain (TM), respec-
tively. To independently test whether the receptor itself makes
part of the pore, a structurally different LTX receptor, NRX Ia,
was also expressed (Fig. 2A). In addition, a LPH-NRX hybrid
was obtained by fusing the cytoplasmic domain of NRX to the C
terminus of LPH-N1TM.
When expressed in COS-7 cells, the recombinant LPH mu-
tants had molecular masses consistent with the addition of
approximately 15 kDa due to glycosylation (Fig. 2B). All these
constructs could be purified from solubilized cells by LTX af-
finity chromatography (not shown), indicating that expression
in non-neuronal cells and the mutagenesis did not abolish the
affinities of the receptors for LTX.
Immunostaining of non-permeabilized cells transfected with
the LPH mutants revealed that most of these proteins were
transported to the plasma membrane (Fig. 3A). However, cells
that abundantly expressed LPH-N1TM (which could be iso-
lated from solubilized cells on an LTX column) did not display
this mutant on their surface and did not bind LTX (see Fig. 4A),
probably because the mutant protein lacked plasma membrane
delivery signals. All the other LPH mutants were surface-
expressed and bound LTX independently of Ca21, although
with different affinities. Thus, LPH-N7TM that lacks only the
cytoplasmic tail was indistinguishable from the full-size LPH
(LPH-FS, Kd ; 4 nM), whereas other constructs containing
fewer transmembrane domains (including the LPH-NRX hy-
brid, not shown) had lower affinities for the toxin and reduced
numbers of receptors on the cell surface (Fig. 3B). COS-7 cells
transfected with NRX also bound the toxin but in a strictly
Ca21-dependent manner (Kd ; 7.5 nM) (Fig. 3B); in addition,
fewer receptor sites were present on the surface of NRX-ex-
pressing cells than in the case of LPH-FS.
LTX-induced Pores Are Permeable to Ca21 and Small Mole-
cules—As shown in Fig. 1E, LTX stimulates 45Ca21 influx into
LPH-expressing COS cells. Similarly, NRX-transfected cells
also accumulated 45Ca21 in the presence of LTX (Fig. 4A). Most
importantly, even LPH mutants unable to activate G proteins
(e.g. LPH-N3TM and LPH-NRX) stimulated pore formation.
After a 5-min exposure to LTX (Fig. 4A), the total amount of
45Ca21 uptake by the receptor-transfected cells correlated with
2 Y. A. Ushkaryov, unpublished data.
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the binding capability of the expressed receptor, i.e. the more
toxin was bound to the cells, the more tracer was accumulated
irrespective of receptor structure. This was also reflected in a
slower initial rate of Ca21 uptake by the NRX cells compared
with the LPH cells (Fig. 4B). This was not due to slower LTX
association with NRX; in fact, toxin binding to NRX reached a
maximum even faster but remained lower than in the case of
LPH (Fig. 4C). Our experiments also directly showed that to
induce the pore, LTX must physically bind to the cell surface
receptor rather than just contact the cell. Indeed, when NRX
cells were treated with 10 nM LTX in the absence of Ca21, they
did not accumulate 45Ca21 added after toxin removal (Fig. 4A).
Previously, we demonstrated that the toxin pores in neuro-
nal plasma membrane are permeable not only to cations but
also to small molecules such as norepinephrine (NE), D-aspar-
tate, and fluorescein isothiocyanate (FITC) (12). This approach
was also used here to study the channels induced by the toxin
in non-neuronal cells. When COS-7 cells, transfected with
LPH, NRX, or vector DNA, were incubated with FITC without
added toxin, they did not accumulate the dye (not shown).
However, when FITC was added in the presence of LTX, recep-
tor-expressing, but not control, cells became fluorescent (Fig.
5A). Upon washout, the dye quickly dissipated from the cytosol,
suggesting that the toxin pore allowed FITC diffusion into and
out of the cytoplasm. Importantly, the nuclei of these cells also
accumulated and retained the dye (Fig. 5A). Diffusion of FITC
from the cytoplasm into the nucleus (probably via the nuclear
pores) strongly suggests that the dye was not simply present in
vesicles taken up by endocytosis.
Neurotransmitters are known to leak out of the neuronal
cytoplasm via the LTX pore (12, 19); therefore, we tested the
permeability of the toxin pore in non-secretory cells to [3H]NE.
COS-7 cells expressing the receptors took up this neurotrans-
mitter but only on the addition of LTX (Fig. 5B); again, uptake
correlated with the toxin binding (not shown). Overall, the
results of the influx experiments suggest that (i) when exoge-
nous receptors are expressed on the surface of cells not nor-
mally responsive to LTX, the toxin permeabilizes the mem-
brane of such cells to cations and small molecules, (ii) the toxin
pores are similar to those made by LTX in neurons containing
native receptors, and (iii) receptor-mediated intracellular sig-
naling is unlikely to be involved in the induction of the pore.
LTX Inserts into the Cell Membrane—To further characterize
the interaction of LTX with the surface of receptor-expressing
COS-7 cells, we used confocal immunofluorescent microscopy.
Upon binding of LTX covalently labeled with a fluorophore
(Cy5), the cells were fixed and then permeabilized to immuno-
stain the C-terminal domains of LPH or NRX with appropriate
fluorescently labeled Abs. We found that the toxin bound only
to the cells expressing recombinant receptors and, as demon-
strated in Fig. 6, A and B, remained on the cell surface where
it co-localized with the receptors in a patchy pattern (arrows).
In the LPH cells, toxin fluorescence coincided with the staining
for LPH at all times (Fig. 6A). However, in the case of NRX,
some of the toxin fluorescence appeared separate from the
receptor staining (Fig. 6B, arrowhead), suggesting that, upon
binding, LTX can remain on the cell surface even in the absence
of direct contact with the receptor protein.
The nature of this toxin interaction with the cell surface was
further studied in NRX-expressing cells because LTX-NRX in-
teraction is strictly Ca21-dependent (11, 12), and the removal
of this cation provides a convenient way to dissociate the toxin
from the receptor. Furthermore, even solubilized NRX does not
interact with the toxin in the absence of Ca21 (12), suggesting
that not only surface-bound but also membrane-inserted LTX
should lose its contact with NRX upon the addition of EGTA.
FIG. 1. LTX only forms pores in membranes containing LTX
receptors. A, examples of channels formed by crude venom. An aliquot
of black widow spider venom containing 10 pM LTX was added to an
equimolar POPE/POPS bilayer cast in 100 mM KCl voltage-clamped at
2100 mV (cis minus trans). K1 currents flowing trans to cis appear as
downwards deflexions. The closed (zero current) level is indicated by
the upper horizontal line. Data were filtered at 100 Hz. B, example of
channel formation by conventional (incompletely purified) LTX. Shown
is a 15-s recording from a POPE bilayer in symmetric 100 mM KCl
voltage-clamped at 2100 mV and exposed to the ion exchange fraction
(25, 34) (containing the equivalent of 1 nM pure LTX) added 2 min
earlier to the cis chamber. Data were filtered at 50 Hz. C, effect of
adding Ca21 and venom to a bilayer exposed to pure LTX. Continuous
recording from a bilayer containing equimolar POPE/POPS/POPC/cho-
lesterol in symmetric 100 mM KCl voltage-clamped at 140 mV and
exposed to 10 nM pure LTX (added by stirring in for 1 min before
starting the recording). 2 mM CaCl2 and venom (containing 10 pM LTX)
were added as indicated. Note the rapid increase in bilayer currents
(upward deflections indicate net positive currents flowing cis to trans)
on adding the venom. D, channel recordings from a very high concen-
tration of pure LTX. 15 s recording from a bilayer containing equimolar
POPE/POPS/POPC/cholesterol in symmetric 250 mM KCl voltage-
clamped at 240 mV and exposed to .100 nM pure LTX, added as a bolus
of 2 mM LTX stock solution to the cis chamber. Channel openings give
rise to downwards deflections, and the upper horizontal line indicates
the main closed level. At least two channels appear to be present. E,
COS-7 cells (106 cells/plate) were transfected with an empty expression
vector or an LPH construct and incubated with 45Ca21 in the presence
or absence of 2 or 100 nM LTX. LTX-stimulated influx of Ca21 into the
cells was measured as described under “Experimental Procedures.”
Values are the mean 6 S.E. At physiological concentrations, LTX stim-
ulates Ca21 accumulation only in cells expressing LPH but not in
control cells; however, very high toxin concentrations can permeabilize
the receptor-deficient cells as well.
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Here, we first allowed the fluorescent LTX derivative to bind to
the NRX cells in a Ca21-containing buffer and then washed the
cells with EGTA. After incubation in the absence of Ca21, the
cells were fixed and immunostained for NRX. As predicted, the
co-localization of the toxin and the receptor largely disap-
peared, although LTX remained on the cell surface (Fig. 6C,
arrowheads). Statistical analysis (Fig. 6D) demonstrates that,
in the presence of Ca21 (left panel), there was no free toxin on
the cells (absence of pixels along the red axis) as it all co-
localized with NRX (spots concentrating along the diagonal).
However, upon Ca21 removal (right panel), almost all cell-
bound toxin appeared separate from NRX (arrowheads). This
could be due to lateral diffusion of membrane-inserted LTX.
To confirm that LTX did indeed insert into the membrane,
we applied toxin to broken membranes from NRX-expressing
cells at low or high temperatures in the presence of Ca21. When
the LTX-NRX interaction was subsequently disrupted by the
addition of EGTA, the bound toxin dissociated from the cells
much faster if the binding had been induced at 4 °C (Fig. 7A);
conversely, when the binding had been done at 28 °C, a large
proportion of LTX remained bound (Fig. 7A; see also Fig. 6D).
Notably, only the initial rate of dissociation was greatly differ-
ent, whereas the later, very slow dissociation phase followed
the same pattern in both cases. This suggests that the residual
LTX binding at both temperatures had the same nature and
was much stronger. Since endocytotic uptake by broken cell
membranes was not possible, the very strong interaction of
LTX with the cell surface was most likely due to membrane
insertion of the toxin, which was facilitated by elevated tem-
peratures. Likewise, temperature strongly affected the inter-
action of the toxin with rat brain nerve terminal membranes,
where LTX displays a lower dissociation constant at 37 °C (Kd
; 1.5 nM) than at 0 °C (Kd . 6 nM) (Fig. 7B, left). At interme-
diate temperatures, both dissociation constants are regularly
observed (Fig. 7B, right) (e.g. Refs. 34 and 35). Importantly,
LTX shows similar two dissociation constants even when only
one receptor (LPH) is expressed in the nerve terminals of NRX
knockout mice (35), indicating that the complex binding pat-
tern is not associated with the presence of two distinct receptor
proteins. Taken together, these findings are consistent with the
idea that LTX binding to receptors is followed by its insertion
into the lipid bilayer, which is facilitated by permissive tem-
peratures, although some incorporation can occur even at low
temperature.
LTX Continues to Form Pores after Dissociating from Recep-
tor—Our interesting observation that LTX stays inserted into
the membrane but can dissociate physically from NRX sug-
gested a method for testing whether this receptor was forming
a part of the toxin-induced pore (Fig. 8A). We therefore studied
the permeability of the cell membrane after LTX had been
allowed to dissociate from NRX. As shown in Fig. 8B, Ca21
(added to NRX-expressing cells after pre-treatment with LTX
and a 10–30-min incubation in the absence of this cation) very
quickly entered the cells through the LTX pore. However, the
re-introduced Ca21 could potentially stimulate some re-associ-
ation of the membrane-inserted LTX with NRX. To avoid this
uncertainty, we looked at the influx of NE through the pre-
formed toxin pores detached from NRX; this allowed us to
monitor the pore in the continued absence of Ca21. Under these
conditions, NE still accumulated in NRX cells (Fig. 8C). More-
over, the pre-formed LTX pores were also permeable to FITC
(Fig. 8D). The influx of both compounds was even stronger in
the absence of Ca21 than in its presence. Thus, the persistence
of the pore was most likely due to the ability of the toxin to form
pores in the membrane even in the absence of its direct inter-
action with NRX.
The LTX Pore Can Be Blocked by Anti-LTX Antibodies—Our
experiments (Figs. 4, 5, and 8) strongly implied that intracel-
lular signaling was not involved in the pore induction but could
not rule out the possibility that LTX, by directly interacting
FIG. 2. LTX receptors and their mu-
tants used in this work. A, the structures,
putative membrane topographies, and no-
menclature of the recombinant receptors. B,
SDS-gel analysis of the receptors and mu-
tants expressed in COS-7 cells. Cells were
transfected with respective constructs and
solubilized as described under “Experimen-
tal Procedures.” Proteins were separated by
electrophoresis (105 cells/lane) in 6% gels,
transferred onto Immobilon membrane, and
stained with the primary Ab (as indicated),
peroxidase-conjugated secondary Ab, fol-
lowed by chemiluminescent visualization.
The upper bands represent dimers of some
mutant proteins. Note that the C-terminal
Ab recognizes LPH-FS whose proteolytic
cleavage (51) is undetectable in this
experiment.
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with receptors or some endogenous cellular proteins, induced
pore formation by these proteins themselves. To provide an
unambiguous demonstration that LTX itself is involved in the
pore structure, we applied anti-LTX Ab to NRX cells containing
pre-formed LTX pores dissociated from the receptor. The im-
mune serum inhibited Ca21 influx through such pores,
whereas the pre-immune serum was ineffective (Fig. 8E). This
result strongly suggests that LTX alone forms the pore.
DISCUSSION
Channel formation by LTX has been puzzling: it was unclear
why this toxin forms pores in lipid bilayers but not in cells that
do not express LTX receptors. Unfortunately, previous work
did not compare the same toxin preparations on both lipid
bilayers and receptor-deficient cells. Such comparison made in
our work proves unequivocally that LTX alone is a very ineffi-
cient pore former; experiments with lipid bilayers and control
COS-7 cells (Fig. 1) demonstrate that pure LTX at concentra-
tions up to 10 nM is unable to form pores in membranes (arti-
ficial or biological) in the absence of LTX receptors. Moreover,
the strong pore-forming activity of the venom gradually disap-
pears with LTX purification. Therefore, previous observations
of pores in artificial lipid membranes made at low nanomolar
LTX concentrations (21–23) must be attributed to residual
FIG. 3. Surface expression of the recombinant receptors and
LTX binding. A, immunolocalization of expressed LPH mutants in
COS-7 cells. To demonstrate the synthesis of mutant proteins, trans-
fected cells were permeabilized and stained with the LPH N-terminal
Ab or NRX C-terminal Ab (left). Surface delivery of the expressed
proteins was assessed using the same Abs on non-permeabilized cells
(right). Note the lack of surface exposure of LPH-1TM despite its abun-
dant production by the cells (NRX cannot be detected in non-permeabi-
lized cells because the Ab only recognizes its cytoplasmic domain). B,
Scatchard plot analysis of LTX binding to some receptors. Cells were
dislodged from plates 24 h after transfection (2 3 105 cells/point), and
their binding of [125I]LTX was measured as explained under “Experi-
mental Procedures.” Note that LPH-7TM has the same binding capacity
and affinity as LPH-FS, whereas LTX binding to NRX, LPH-5TM, and
LPH-N3TM is 2-, 4.5-, and 3-fold weaker, respectively. LPH-1TM lack-
ing all but the first transmembrane domain does not bind LTX due to
the lack of surface delivery.
FIG. 4. LTX pores in receptor-expressing COS cells are perme-
able to Ca21. A, specific binding of [125I]LTX to and influx of Ca21 into
cells transfected with different receptor constructs. The binding to the
cells in situ was measured 24 h after transfection (3 3 105 cells/well). In
parallel, the cells were incubated with 45Ca21 in the presence of 1 nM
LTX. The cells accumulated the radioactive tracer in accordance with
their binding of the toxin. In some experiments, before the addition of
45Ca21, LTX had been added to the cells in the absence of this cation
(0.2 mM EGTA) and then washed away (Binding in EGTA); subse-
quently, Ca21 was taken up only by the LPH, but not the NRX, cells.
Data (6S.E.) are from a representative experiment done in triplicate. B,
rate of Ca21 influx. Cells expressing LPH-FS or NRX were incubated
with 45Ca21 as above; upon the addition of 1 nM LTX, the cells were
harvested after specified periods of time. Data (6S.E.) are from two
independent experiments. C, time course of specific (spec.) LTX binding.
The LPH and NRX cells were incubated with 1 nM [125I]LTX, and the
amount of bound toxin was determined after the same time periods as
in B. Data are from representative experiments carried out in duplicate.
Note that the rate of Ca21 influx is slower in NRX-expressing cells,
probably due to a lower amount of bound toxin.
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contamination by other venom components. Indeed, LTX used
in bilayer experiments was routinely purified by one-step ion-
exchange chromatography (e.g. Refs. 22 and 23), although even
the original paper describing toxin purification pointed out the
incomplete homogeneity of LTX even after a two-step proce-
dure (26). The large variety of channels obtained with the crude
venom (Fig. 1A) and with different toxin preparations (e.g.
Refs. 17, 23, 28, 36, and 37) also suggests that other venom
components either form channels themselves or help LTX to
insert into the membrane. In fact, at concentrations above 100
nM, the pure toxin can insert into liposomes (24), planar bilay-
ers (Fig. 1D), and biological membranes (Fig. 1E). However,
receptors present on the cell surface facilitate LTX pore forma-
tion by more than 100-fold (Fig. 1E).
What is the role of the receptors in membrane pore formation
by LTX? When the toxin pores are studied in native secretory
cells (neuroblastoma (17), chromaffin cells (6), gonadotropes
(38)) or in secretory cells transfected with exogenous receptors
(39, 40), one cannot totally exclude the involvement of intra-
cellular signaling in pore induction because such cells possess
endogenous NRX and LPH as well as receptor-linked pathways
and non-receptor exocytotic proteins. Similarly, injection of
non-secretory cells (Xenopus oocytes) with heterogeneous neu-
ronal mRNA cannot demonstrate which receptor(s) or other
neuronal proteins are involved in LTX pore formation (28). A
more analytical approach was used in recent work (37, 41)
based on electrophysiological characterization of LTX pores
induced in non-secretory (HEK293 and BHK, respectively) cells
transfected only with LPH, NRX, or mutant receptors. The
results demonstrated that LTX makes pores on binding to any
of its receptors.
In our present work too, introduction of LTX-binding pro-
teins, including various receptor mutants, into non-secretory
cells rendered them susceptible to the pore-forming activity of
the toxin (Figs. 1, 4, 5, and 8). COS-7 cells are not capable of
regulated exocytosis and lack most of the components of the
exocytotic machinery present in endocrine or neuronal cells.
FIG. 5. LTX pores are permeable to small molecules. A, LPH-,
NRX-, or vector-transfected COS cells were treated with 4 nM LTX for
10 min in the absence or presence of 2 mM Ca21 (as indicated), washed
and incubated with 5 mM FITC, and quickly washed and imaged by
confocal microscopy. N, nucleus. Note that only receptor-expressing
cells are permeable to FITC and only upon the addition of LTX. Scale
bars, 20 mm. B, influx of [3H]NE into LPH- or vector-transfected cells
(details under “Experimental Procedures”). Values (normalized for
transfected cells) are the mean 6 S.E. from a representative
experiment.
FIG. 6. Co-localization of LTX with receptors in cell mem-
brane. A and B, LPH- and NRX-expressing cells were incubated with
Cy5-labeled LTX in buffer A containing 2 mM CaCl2 for 10 min, washed,
fixed, and stained with respective anti-receptor Ab, and visualized by
confocal fluorescent microscopy. Scale bars, 20 mm. Note the complete
co-localization of LTX with the LPH C-terminal staining (arrows) and
partial co-localization of LTX and NRX (free toxin is shown by an
arrowhead). C, LTX remains membrane-bound after dissociating from
receptor in NRX-expressing cells. The NRX cells were first incubated for
10 min with LTX in the presence of 2 mM Ca21, washed with 0.2 mM
EGTA, incubated in an EGTA-containing buffer for a further 10–30
min, then fixed and immunostained with anti-NRX Ab as above. D,
scatter diagrams (see “Experimental Procedures”) showing analysis of
co-localization of Cy5-labeled LTX with immunostained NRX after in-
cubation of cells in the continued presence of Ca21 (left, n 5 6) or after
subsequent removal of cation (right, n 5 9). Spots along the diagonal
line correspond to LTX co-localizing with NRX; spots along the x axis
(arrowheads) correspond to free toxin.
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Thus, specific neuronal proteins cannot be involved in the
formation of the toxin pore in these cells. In addition, pore
formation depends on the amount of bound LTX rather than on
the type of receptor expressed (Fig. 4). Moreover, even receptor
mutants that cannot mediate signaling (LPH-5TM, LPH-3TM,
and LPH-NRX) allow the toxin to form pores, indicating that
signal transduction is not involved in the induction of the pore.
Do LPH or NRX contribute to the structure of the pore or just
recruit the toxin to the membrane? LPH and NRX have very
different membrane domain structures; therefore, if the recep-
tors indeed formed the pore together with LTX, such pores
would have had different characteristics. However, the pores
induced by LTX in HEK293 or BHK cells transfected with LPH,
NRX, or their mutants have very similar electrophysiological
parameters (37, 41). In our experiments too, the features of the
toxin pores do not depend on the receptor structure (Figs. 4, 5,
and 8). Furthermore, at least in the case of NRX, the toxin can
dissociate from the receptor and remain in the membrane
(Figs. 6 and 7), continuing to form pores with the same macro
characteristics (Fig. 8). Although such dissociation apparently
cannot be achieved for LPH, this receptor is also unlikely to be
physically involved in the pore because its mutants with dif-
ferent numbers of transmembrane domains support the induc-
tion of similar LTX pores (Fig. 4 and data not shown).
Thus, our results suggest that the toxin itself forms pores,
but how does this hydrophilic toxin insert into the membrane?
Using cryo-electron microscopy, we recently visualized the
toxin pores in the membrane of liposomes and revealed the
likely mechanism of pore formation (24). LTX in solution exists
as a homodimer (24, 25), but when its local concentration
increases (e.g. upon receptor binding) and, especially in the
presence of divalent cations (25), the dimers assemble into
tetramers; this rearrangement renders one side of the tetramer
FIG. 7. LTX interaction with the membrane of receptor-ex-
pressing cells is temperature-dependent. A, membranes from
NRX-transfected COS cells (corresponding to 2 3 105 cells/point) were
incubated with [125I]LTX in suspension in the presence of 2 mM Ca21 at
0–4 or 28 °C (as indicated) and quickly washed with an ice-cold buffer
containing 5 mM EGTA. Toxin remaining bound to these membranes
was measured by filtration. Note that the initial rate of LTX dissocia-
tion is much slower if the binding was carried out at high temperature.
Values are mean 6 S.E. B, Scatchard plots of [125I]LTX interaction with
rat brain synaptosomes (1 mg of protein/ml). The binding was measured
at 0 or 37 °C (left, as indicated) or at 20 °C (right). The respective Kd
values are 1.6 nM (37 °C) and .6 nM (0 °C). At 20 °C, the two consti-
tuting types of binding are shown by dotted lines. B, bound [125I]LTX; F,
free [125I]LTX concentration.
FIG. 8. LTX pores are still active even after dissociating from
receptor. A, scheme of the experiment. LTX was bound to NRX-trans-
fected cells (3 3 105 cells/well) for 10 min in 0.1 mM Ca21, and the cells
were washed with 0.2 mM EGTA. After a 10–30-min incubation at room
temperature in a Ca21-free buffer, 45Ca21, [3H]NE, or FITC was added,
and the accumulation of each substance by the cells was measured
using an appropriate method. B–D, the cells prepared as in A were
incubated for 5 min with 2 mM Ca21/45Ca21 or for 5 min with 0.5–2.5
mCi of [3H]NE or 5 mM FITC in an EGTA-containing buffer. Scale bar,
20 mm. E, LTX pores can be blocked by anti-LTX Ab. LTX pores were
pre-formed in NRX-expressing cells as in A, and the pre-immune or
anti-LTX serum was included during the 30-min incubation (1:20 dilu-
tion). 2 mM Ca21/45Ca21 was then added, and the influx of 45Ca21 was
measured after 5 min as described under “Experimental Procedures.”
Values are mean 6 S.E. from representative experiments repeated
several times in duplicate.
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hydrophobic. The tetramers can then incorporate into a lipid
bilayer. In the center, the tetramer has a channel of 10–25 Å in
diameter that spans the membrane. Strikingly, a very similar
diameter (;19 Å) was estimated for LTX water pores in lipid
bilayers (23). Our tetramer/pore model (24, 25) is consistent
with the permeability of the toxin pore to different cations,
amino acids, NE, and FITC (largest dimension, 12 Å) but not to
small dextrans or cytoplasmic proteins (12, 14). Based on this
model, the receptors may act both by increasing the near-
membrane toxin concentration (thus, aiding LTX tetrameriza-
tion) and by orientating the tetramers with their hydrophobic
side toward the membrane. Receptors serving as specific an-
chors for inefficient pore-forming toxins can also explain the
phylum specificity of the members of latrotoxin family, which
have very similar mechanisms of action but only interact with
receptors in their target animals (26, 42).
Can pore formation by LTX explain all of its dramatic effects
on a secretory cell? We showed that most of LTX-induced se-
cretion correlates directly with formation of tetramers and
pores (25). Massive influx of Ca21 and other cations through
these pores can stimulate exocytosis directly (6, 17, 40, 43) or
indirectly by mobilizing intracellular Ca21 (12, 17, 38, 44); in
addition, leakage of cytosolic constituents (12, 19, 20) can fur-
ther destabilize and stimulate the cell. But do the receptors
mediate at least some of LTX action? To answer this question
properly, one should use a LTX derivative that is unable to
form pores; otherwise, the robust effects of the membrane pore
always mask the subtle receptor-mediated mechanisms. In-
deed, even signaling-deficient receptor mutants, by binding
LTX, support toxin pore formation and Ca21 influx. Ironically,
an increased sensitivity of endocrine cells to LTX (in the pres-
ence of Ca21) upon super-transfection with receptor mutants
was used to suggest that the receptors do not transmit exocy-
totic signals (40, 45, 46). However, neither these results nor the
data presented in this paper exclude the possibility that recep-
tor-mediated signaling may be involved in some aspects of
secretion stimulated by LTX, especially at low extracellular
Ca21, as has been suggested by many authors (12, 14, 39, 44,
47). Thus, although the pore formation is very important for
the action of the toxin, the natural role of LTX receptors re-
mains uncertain. Future work will be needed to address the
functions of both LTX receptors.
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